Partner Content Partner Content Pharmacovigilance Market Size will achieve 10.6% CAGR up to ... Pharmacovigilance Market to hit $8.9 bn by 2025
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
